Advertisement

Inducible System Designed for Future Gene Therapy

  • Yaolin Wang
  • Bert W. O’Malley
  • Sophia Y. Tsai
Part of the Methods in Molecular Biology™ book series (MIMB, volume 63)

Abstract

Gene therapy involves the introduction of foreign therapeutic genes into humans to treat certain diseases. In current protocols, the expressions of the delivered foreign genes are under the control of a constitutive promoter. However, most genes are regulated under physiological conditions in response to various stimuli, including metabolites, growth factors, and hormones. Constitutive expression of foreign genes may result in cytotoxicity as well as undesired immune responses. In order to further the development of gene therapy, it is essential to regulate the expression of the genes once they are delivered into the body.

Keywords

Tyrosine Hydroxylase Human Growth Hormone Inducible System Tyrosine Hydroxylase Gene Exogenous Signal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Reference

  1. 1.
    Searle, P. F., Stuart, G. W., and Palmiter, R. (1985) Building a metal-responsive promoter with synthetic regulatory elements. Mol. Cell Biol. 5, 1480–1489.PubMedGoogle Scholar
  2. 2.
    Fuqua, S. A., Blum-Salingaros, M., and McGuire, W. L. (1989) Induction of the estrogen-regulated “24K” protein by heat shock. Cancer Res. 49, 4126–4129.PubMedGoogle Scholar
  3. 3.
    Hirt, R. P., Fasel, N., and Kraehenbuhl J.-P. (1994) Inducible protein expression using a glucocorticoid-sensitive vector. Methods Cell Biol. 43, 247–262.PubMedCrossRefGoogle Scholar
  4. 4.
    Figge, J., Wright, C., Collins, C. J., Roberts, T. M., and Livingston, D. M. (1988) Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E coli lac repressor in monkey cell. Cell 52, 713–722.PubMedCrossRefGoogle Scholar
  5. 5.
    Baim, S. B., Labow, M. A., Levine, A. J., and Shenk, T. (1991) A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl b-D-thiogalactrpyranoside. Proc. Natl._Acad. Sci. USA 88, 5072–5076.PubMedCrossRefGoogle Scholar
  6. 6.
    Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl._Acad. Sci. USA 89, 5547–5551.PubMedCrossRefGoogle Scholar
  7. 7.
    Gossen, M., Boninm, A. L., Freudlieb, S., and Bujard, H. (1994) Inducible gene expression systems for higher eukaryotic cells. Curr. Opin. Biotechnol. 5, 516–520.PubMedCrossRefGoogle Scholar
  8. 8.
    Furth, P. A., Onge, L. T., Boger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., and Hennighausen, L. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302–9306.PubMedCrossRefGoogle Scholar
  9. 9.
    Picard, D. (1994) Regulation of protein function through expression of chimaeric proteins. Curr. Opin. Biotechnol. 5, 511–515.PubMedCrossRefGoogle Scholar
  10. 10.
    Jackson, P., Baltimore, D., and Picard, D. (1993) Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants. EMBO J. 12, 2809–2819.PubMedGoogle Scholar
  11. 11.
    Braselmannm, S., Graninger, P., and Busslinger, M. (1993) A selective transcriptional induction system for mammalian cells based on GAL4-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. USA 90, 1657–1661.CrossRefGoogle Scholar
  12. 12.
    Klaassen, C. (1985) Heavy metals and heavy-metal antagonists, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutic (Gilman, A. G., Goodman, L. S., Rall, T. W., and Murad., F., eds.), Macmillan, New York, pp. 1617–1619.Google Scholar
  13. 13.
    Roemer, K. and Friedmann, T. (1993) Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein. Proc. Natl. Acad. Sci. USA 90, 9252–9256.PubMedCrossRefGoogle Scholar
  14. 14.
    Schuermann, M., Henning, G., and Muller, R. (1993) Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion. Oncogene 8, 2781–2790.PubMedGoogle Scholar
  15. 15.
    Sande, M. A. and Mandell, G. L. (1985) Antimicrobial agents, in Goodman and Gilman’s: The Pharmacological Basis of Therapeutic (Gilman, A. G., Goodman, L. S., Rail, T. W., and Murad, F., eds.), Macmillan, New York, pp. 1174–1176.Google Scholar
  16. 16.
    Gossen, M., Freundlieb, S., Bender, G., Kitner, A., Baron, U., Muller, G., Hillen, W., and Bujard, H. (1995) Exploiting prokaryotic elements for the control of gene activity in higher eukaryotics. J. Cell. Biochem. (Suppl. 21A),C6-004, 355.Google Scholar
  17. 17.
    Spencer, D. M., Wnadless, T. J., Schreiber, S. L., and Crabtree, G. R. (1993) Control of signal transduction with synthetic ligands. Science 262, 1019–l024.PubMedCrossRefGoogle Scholar
  18. 18.
    Wang, Y., O’Malley, B. W. O., Jr., Tsai, S. Y., and O’Malley, B. W. O. (1994) A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91, 8180–8184.PubMedCrossRefGoogle Scholar
  19. 19.
    Brogden, R. N., Goa, K. L., and Faulds, D. (1993) Mifepristone, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45, 384–409.PubMedCrossRefGoogle Scholar
  20. 20.
    Grunberg, S. M., Weiss, M. H., Spitz, I. M., Ahmadi, J., Sadun, A., Russell, C. A., Lucci, L., and Stevenson, L. L. (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J. Neurosurg. 74, 861–866.PubMedCrossRefGoogle Scholar
  21. 21.
    Lin, Y.-S., Carey, M. F., Ptashne, M., and Green, M. R. (1988) GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell 52, 713–722.CrossRefGoogle Scholar
  22. 22.
    Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407–4411.PubMedCrossRefGoogle Scholar
  23. 23.
    Gallagher, S. R. E. and Smith, J. A. (1992) Denaturing (SDS) discontnuous gel electrophoresis. Laemmli gel method, in Current Protocols in Molecular Biology (Ausubel, F. M., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds.), John Wiley, New York, pp. 10.2.4–10.2.9.Google Scholar
  24. 24.
    Holmes, D. S. and Quigley, M. (1981) A rapid boiling method for the preparation of bacterial plasmids. Anal. Biochem. 114, 193–197.PubMedCrossRefGoogle Scholar
  25. 25.
    Heilig, J. S., Lech, K., and Brent, R. (1992) Large-scale preparation of plasmid DNA-CsC1/ethidium bromide equilibrium Centrifugation, in Current Protocols in Molecular Biology (Ausubel, F. M., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds.), John Wiley, New York, pp. 1.7.5–1.7.11.Google Scholar
  26. 26.
    Yan, C., Costa, R. H., Darnell, J. E., Jr., Chen, J., and Van Dyke, T. A. (1990) Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9, 869–878.PubMedGoogle Scholar
  27. 27.
    Kingston R. E. (1992) Calcium phosphate transfection, in Current Protocols in Molecular Biology (Ausubel, F. M., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds.), John Wiley, New York, pp. 9.1.1–9.1.3.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1997

Authors and Affiliations

  • Yaolin Wang
    • 1
  • Bert W. O’Malley
    • 1
  • Sophia Y. Tsai
    • 1
  1. 1.Department of Cell BiologyBaylor College of MedicineHouston

Personalised recommendations